China Traditional Chinese Medicine Holdings Co. Limited (HKG:0570)
1.820
+0.030 (1.68%)
At close: Mar 27, 2026
HKG:0570 Revenue
In the year 2025, China Traditional Chinese Medicine Holdings Co. had annual revenue of 14.74B CNY, down -10.69%. China Traditional Chinese Medicine Holdings Co. had revenue of 7.28B in the half year ending December 31, 2025, a decrease of -17.43%.
Revenue
14.74B CNY
Revenue Growth
-10.69%
P/S Ratio
0.56
Revenue / Employee
946.21K CNY
Employees
15,583
Market Cap
9.17B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 14.74B | -1.76B | -10.69% |
| Dec 31, 2024 | 16.51B | -1.61B | -8.90% |
| Dec 31, 2023 | 18.12B | 3.82B | 26.69% |
| Dec 31, 2022 | 14.30B | -4.75B | -24.92% |
| Dec 31, 2021 | 19.05B | 4.25B | 28.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shandong Xinhua Pharmaceutical Company | 9.28B |
| Luye Pharma Group | 6.76B |
| SSY Group | 4.58B |
| China Shineway Pharmaceutical Group | 3.66B |
| Consun Pharmaceutical Group | 3.58B |
| Sihuan Pharmaceutical Holdings Group | 2.30B |
| Beijing Tong Ren Tang Chinese Medicine Company | 1.51B |
| CanSino Biologics | 1.19B |